Novel biomarkers in Polycystic Ovary Syndrome-Reference-Cited by-同舟云学术

Novel biomarkers in Polycystic Ovary Syndrome

Published:2024-01-19 Issue: Volume: Page:439-442
ISSN:0974-360X
Container-title:Research Journal of Pharmacy and Technology
language:en
Short-container-title:RJPT

Author:

Kaur Chahal Simerjeet¹,Kabra Atul¹,Kaur Sodhi Rupinder²

Affiliation:

1. University Institute of Pharmaceutical Sciences, Chandigarh University, Gharuan, Mohali - 140413, Punjab, India.

2. Department of Pharmacology, Chandigarh College of Pharmacy, Mohali (Punjab) India.

Abstract

Polycystic ovary syndrome (PCOS) is an alarming gynaecological endocrine disorder affects women of reproductive age. Hyperandrogenism contributes for a cluster of cardio-metabolic risk factors characterized by reproductive dysfunction, polycystic ovaries, anovulation, and cosmetic dysfunctions. Although during the past decades, substantial research efforts tried to uncover the exact aetiology and pathogenesis of PCOS but owing to the complex etiology, the patho-physiological mechanisms of PCOS remains in doubt. To develop potential and highly efficient therapeutic strategies, there are many proteins which can act as potential biomarkers for PCOS. These biomarker proteins and enzymes may involve in the early detection and handling of this condition and mitigate the risk of long-term problems.

Publisher

A and V Publications

Reference44 articles.

1. Tabrizi FPF, Hajizadeh-Sharafabad F, Vaezi M., Jafari-Vayghan H, Alizadeh M and Maleki V. Quercetin and polycystic ovary syndrome,current evidence and future directions: asystematic review. J Ovarian Res. 2020; 13:11.

2. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016; 106(1):6-15. doi: 10.1016/j.fertnstert.2016.05.003.

3. Carvalho LML, Ferreira CN, Soter MO, Sales MF, Rodrigues KF, Martins SR, et al. Microparticles: Inflammatory and haemostatic biomarkers in Polycystic Ovary Syndrome. Mol Cell Endocrinol. 2017a; 443:155-162.

4. Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, et al. Reproductive Medicine Network. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015; 6(1):7502.

5. Hao CF, Zhang N, Qu Q, Wang X, Gu HF, Chen ZJ.Evaluation of the association between the CYP19 Tetranucleotide (TTTA) n polymorphism and polycystic ovarian syndrome (PCOS) in Han Chinese women.Neuro Endocrinol. Lett. 31 (3) (2010), 370-374.